Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?-Reference-Cited by-同舟云学术

Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction?

Published:2009-07 Issue:7 Volume:9 Page:1045-1058
ISSN:1473-7175
Container-title:Expert Review of Neurotherapeutics
language:en
Short-container-title:Expert Review of Neurotherapeutics

Author:

Citrome Leslie,Kantrowitz Joshua T

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Neurology (clinical),General Neuroscience

Link

http://www.tandfonline.com/doi/pdf/10.1586/ern.09.54

Reference76 articles.

1. Eli Lilly and Company. Zyprexa (olanzapine). In:Physicians’ Desk Reference, 2009, 63rd Edition.Physicians ’ Desk Reference Inc., Montvale, NJ, USA, 1883–1891 (2008).

2. Dose Response and Dose Equivalence of Antipsychotics

3. A Meta-analysis of the Efficacy of Second-Generation Antipsychotics

4. Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks

5. Dosing of Second-Generation Antipsychotic Medication in a State Hospital System

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions;Pharmacogenomics and Personalized Medicine;2023-12

2. Second International Consensus Study of Antipsychotic Dosing (ICSAD-2);Journal of Psychopharmacology;2023-10

3. Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia;American Journal of Psychiatry;2023-05-01

4. High-dose olanzapine in treatment-resistant schizophrenia: a systematic review;Therapeutic Advances in Psychopharmacology;2023-01

5. Opţiuni terapeutice în schizofrenia ultrarezistentă. Intervenţii farmacologice (I);Psihiatru.ro;2023